# Sexual desire studies of kisspeptin

> Desire and the scanner | Ripple Peptides — Ripple Peptides looks closely at kisspeptin research in men with low sexual desire, separating brain responses, physical arousal and self-reports.

**4**

Brain activity, physical arousal and reported desire appear in the same literature. Each measures something different.

## The HSDD trial participants

I underestimated this part of the literature at first. The reproductive hormone studies made the brain-imaging work seem like a side issue. Then [the randomized double-blind crossover trial in 32 men with hypoactive sexual desire disorder](https://pubmed.ncbi.nlm.nih.gov/36735255/) put several kinds of observation together: kisspeptin-54 modulated sexual-processing brain networks, increased penile tumescence by up to 56% over placebo and heightened self-reported sexual desire. No adverse events were reported in this trial.

Tumescence means swelling, the physical arousal measurement here. The phrase “up to” matters to that percentage. For me, treating the largest reported increase as every participant's experience would spoil a useful finding about a specific group and particular measurements. The result is substantial enough to take seriously in the population that was actually enrolled.

![A technician looks through a control-room window toward an empty MRI scanner.](images/scanner-control-room.webp)

*A staged imaging-workspace scene; the technician is an illustrative operator, and the scanner contains no patient.*

## Visual and olfactory cues

Earlier [functional neuroimaging research in men](https://pubmed.ncbi.nlm.nih.gov/32051344/) found enhanced activity in olfactory and limbic regions in response to visual and olfactory cues of attraction during kisspeptin administration. The largest effects occurred in men reporting lower sexual quality of life. This was a finding about responses to particular cues in an experimental setting.

To me, that relationship to the men's starting experience makes the study more interesting than an undifferentiated claim about increasing attraction. It suggests a question worth investigating in people with difficulties, while leaving the circumstances of the measured response visible. The experiment has a stimulus, an instrument and an outcome; all three help explain what was observed.

## Desire beyond the scanner

The [trial in men with hypoactive sexual desire disorder](https://pubmed.ncbi.nlm.nih.gov/36735255/) brought the psychosexual question into sharper focus for me. It combined imaging with a physical response and self-reported desire, so there was more to consider than an image of an active brain region.

What matters next is whether these experimental findings translate into lasting relief in everyday life. These experimental observations leave that question open for me. An evoked response can be important without telling the whole story of a continuing difficulty, and the distinction becomes especially consequential when the outcome is something as personal as desire.

## Anxiety was measured separately

I also had to loosen the assumption that all effects described as emotional would move together. In [the crossover trial that measured anxiety](https://pubmed.ncbi.nlm.nih.gov/40036336/), reproductive hormone activity increased while state anxiety did not change significantly versus placebo. An effect on sexual-processing circuitry gives no shortcut to the result of a different psychological measurement.

[The appetite and anxiety essay](/quiet-results) stays with those unchanged outcomes. They make the reach of the signal more specific, which makes the positive findings easier to understand as well.

---

At Ripple Peptides I follow kisspeptin through the published experiments and argue over the consequences, with essays to think about rather than medical advice to act on.